Apr, 2017

U.S.A.
News / Corporate
Astellas Reports Full Year FY2016 Financial Results
Sales decreased (-4.4%) on a reported basis and increased approximately 2% excluding the factors associated with the transfer of the global dermatology business implemented in April 2016 and the...
Read More

Feb, 2017

U.S.A.
News / Corporate
Astellas Names Linda Friedman General Counsel for Worldwide Legal Organization and Executive Committee Member
Astellas today announced the promotion of Linda Friedman as executive vice president, general counsel, with responsibility for the company's Legal organization worldwide, effective April 1, 2017....
Read More

Jan, 2017

U.S.A.
News / Corporate
Astellas Reports the First Nine Months Financial Results of FY2016
- Sales decreased (-5.6%) on reported basis and increased approximately 3% on a constant currency basis; Increased core operating profit (+3.4%) and core profit (+4.6%) - Sales of XTANDI®...
Read More
U.S.A.
News / Corporate
Astellas Announces Participation in Access Accelerated
Astellas Pharma Inc. (President and CEO: Yoshihiko Hatanaka, "Astellas" ) today announced its participation in Access Accelerated, a global, multi-stakeholder initiative to advance access to...
Read More

Dec, 2016

U.S.A.
News / Corporate
Astellas Completes Acquisition of Ganymed Pharmaceuticals
Astellas Pharma Inc. (TSE: 4503, President and CEO: Yoshihiko Hatanaka, "Astellas" ) today announced that it has completed the acquisition of Ganymed Pharmaceuticals AG ("Ganymed"), a...
Read More